XML 59 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended
Apr. 30, 2024
Apr. 12, 2024
Mar. 31, 2024
Mar. 22, 2024
Mar. 07, 2024
Mar. 06, 2024
Feb. 06, 2024
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2024
Sep. 30, 2024
Sep. 30, 2024
Jun. 15, 2024
Mar. 05, 2024
Feb. 29, 2024
Subsequent Events (Details) [Line Items]                              
Number of shares granted (in Shares)                       1,287,760      
Percentage of development costs                       50.00%      
Reimburse of development costs               $ 3,300              
Research and development expense [1]                     $ 25,691 $ 49,557      
Gross proceeds     $ 3,000                        
Converted into shares value                       $ 2,931      
Lease term                     1 year 1 year 39 months 15 days    
Lease payment                       $ 74      
Clinical Development Milestones [Member]                              
Subsequent Events (Details) [Line Items]                              
Non-refundable milestone payments             $ 12,000   $ 12,000            
Certain Regulatory Milestones [Member]                              
Subsequent Events (Details) [Line Items]                              
Non-refundable milestone payments             $ 10,000   $ 10,000            
Warrant [Member]                              
Subsequent Events (Details) [Line Items]                              
Percentage of warrant purchase             1.00%                
Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Price per share (in Dollars per share)           $ 0.15                  
Research initiation fee           $ 800                  
Percentage of development costs     50.00%     50.00%                  
Research and development expense                   $ 900          
Gross proceeds from common stock           $ 50,000                  
Lease term   39 months 15 days                          
Lease payment   $ 1,400                          
Subsequent Event [Member] | Common Stock [Member]                              
Subsequent Events (Details) [Line Items]                              
Price per share (in Dollars per share)           $ 12                  
Subsequent Event [Member] | Option [Member]                              
Subsequent Events (Details) [Line Items]                              
Number of shares granted (in Shares)       399,222 779,971                    
Board of Directors [Member] | Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Restricted stock awards authorized (in Shares)     1,022,804           1,022,804 1,022,804         1,184,749
Price per share (in Dollars per share)     $ 0.0001           $ 0.0001 $ 0.0001         $ 0.0001
Convertible Notes [Member] | Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Principal amount           $ 25,000                  
Converted into shares value           $ 25,000                  
Interest rate           12.00%                  
Convertible Notes [Member] | Subsequent Event [Member] | Convertible Note Purchase Agreement [Member]                              
Subsequent Events (Details) [Line Items]                              
Principal amount           $ 30,000                  
2024 Plan [Member] | Minimum [Member] | Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Number of shares of common stock available for issuance (in Shares)         498,789                 213,085  
2024 Plan [Member] | Maximum [Member] | Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Number of shares of common stock available for issuance (in Shares)         1,179,193                 498,789  
Paragon [Member]                              
Subsequent Events (Details) [Line Items]                              
Research initiation fee             $ 800                
Paragon [Member] | Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Accrued development costs           $ 5,900                  
Payment to related party $ 3,300                            
Series A Preferred Stock [Member]                              
Subsequent Events (Details) [Line Items]                              
Preferred stock, shares issued (in Shares)                     2,439,000 2,439,000      
Series A Preferred Stock [Member] | Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Price per share (in Dollars per share)           $ 0.15                  
Preferred stock, shares issued (in Shares)           20,000,000                  
Gross proceeds           $ 3,000                  
Stock issuance cost           $ 100                  
Conversion price per share (in Dollars per share)           $ 0.5712                  
Series A Preferred Stock [Member] | Convertible Notes [Member] | Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Principal amount           $ 25,000                  
Series A Convertible Preferred Stock [Member] | Subsequent Event [Member]                              
Subsequent Events (Details) [Line Items]                              
Conversion price per share (in Dollars per share)           $ 0.26                  
[1] Includes related party amount of $13,537 for the three months ended September 30, 2024 and $33,967 for the period from February 6, 2024 (inception) to September 30, 2024